2618 Federal Register / Vol. 74, No. 10 / Thursday, January 15, 2009 / Notices 

—Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Overview of this information 

collection: 

(1) Type of Information Collection: 

Extension of a currently approved 

collection. 

(2) Title of the Form/Collection: 

Certification of Secure Gun Storage or 

Safety Devices. 

(3) Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: Form Number: ATF F 

5300.42. Bureau of Alcohol, Tobacco, 

Firearms and Explosives. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Business or other forprofit. Other: None. The requested 

information will be used to ensure that 

applicants for a federal firearms license 

are in compliance with the requirements 

pertaining to the availability of secure 

gun storage or safety devices. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: It is estimated that 61,641 

respondents will complete a 1 minute 

form. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: There are an estimated 1,233 

annual total burden hours associated 

with this collection. 

If additional information is required 

contact: Lynn Bryant, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

Department of Justice, Patrick Henry 

Building, Suite 1600, 601 D Street NW., 

Washington, DC 20530. 

Dated: January 9, 2009. 

Lynn Bryant, 

Department Clearance Officer, PRA, United 

States Department of Justice. 

[FR Doc. E9–737 Filed 1–14–09; 8:45 am] 

BILLING CODE 4410–FY–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated October 9, 2008, and 

published in the Federal Register on 

October 17, 2008 (73 FR 61908), 

Noramco Inc., 500 Swedes Landing 

Road, Wilmington, Delaware 19801– 

4417, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as an importer of 

Opium, Raw (9600) and Concentrate of 

Poppy Straw (9670), basic classes of 

controlled substances listed in schedule 

II. 

The company plans to import the 

listed controlled substances to 

manufacture other controlled 

substances. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and § 952(a) 

and determined that the registration of 

Noramco, Inc., to import the basic class 

of controlled substance is consistent 

with the public interest, and with 

United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated 

Noramco, Inc., to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: January 9, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–773 Filed 1–14–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated October 9, 2008, and 

published in the Federal Register on 

October 17, 2008, (73 FR 61909), 

Formulation Technologies LLC., 11400 

Burnet Road, Suite 4010, Austin, Texas 

78758, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as an importer of 

Fentanyl (9801), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import the 

listed controlled substance for analytical 

characterization, secondary packaging, 

and/or for distribution to clinical trial 

sites. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Formulation Technologies LLC. to 

import the basic class of controlled 

substance is consistent with the public 

interest, and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971, at this time. DEA has 

investigated Formulation Technologies 

LLC. to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: January 9, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–720 Filed 1–14–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated October 9, 2008, and 

published in the Federal Register on 

October 17, 2008, (73 FR 61908), Fisher 

Clinical Services, Inc., 7554 Schantz 

Road, Allentown, Pennsylvania 18106, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as an importer of 

Noroxymorphone (9668), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import the 

listed controlled substance for analytical 

research and clinical trials. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Fisher Clinical Services, Inc. to import 

the basic class of controlled substance is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated Fisher 


jlentini on PROD1PC65 with NOTICES